JSVTX | JVMAX | JSVTX / JVMAX | |
Total Expense Ratio | 0.94 | 1.12 | 84% |
Annual Report Gross Expense Ratio | 1.17 | 1.13 | 104% |
Fund Existence | 14 years | 28 years | - |
Gain YTD | 1.588 | 8.812 | 18% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 84.5M | 23.6B | 0% |
Annual Yield % from dividends | 0.40 | 0.57 | 70% |
Returns for 1 year | -3.90 | -0.08 | 5,159% |
Returns for 3 years | 20.94 | 10.24 | 205% |
Returns for 5 years | 52.12 | 46.94 | 111% |
Returns for 10 years | 33.71 | 39.65 | 85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 33.03 | 0.28 | +0.85% |
Fidelity Advisor Biotechnology I | |||
PNEAX | 10.54 | N/A | N/A |
Virtus NFJ Dividend Value A | |||
PWCIX | 88.75 | -0.23 | -0.26% |
Principal Capital Appreciation Inst | |||
IMCGX | 11.18 | -0.06 | -0.53% |
Transamerica Mid Cap Growth I | |||
ISMVX | 10.73 | -0.07 | -0.65% |
William Blair Small-Mid Cap Value I |